SCHEMBL30987649

SCHEMBL30987649

COC(=O)c1ccc(-c2cncs2)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC4 P56524 1/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ SENP8 Q96LD8 1/20 0.41
▸ SENP7 Q9BQF6 1/20 0.41
▸ SENP6 Q9GZR1 1/20 0.41
▸ CD38 P28907 5/20 0.41
▸ IMPDH2 P12268 1/20 0.40
▸ IMPDH1 P20839 1/20 0.40
▸ ABL1 P00519 1/20 0.39
▸ LRRK2 Q5S007 1/20 0.39
▸ GSK3B P49841 2/20 0.38
▸ DYRK1A Q13627 2/20 0.38
▸ CLK2 P49760 1/20 0.38
▸ WNT1 P04628 1/20 0.38
▸ SLC6A4 P31645 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.38
▸ NR4A2 P43354 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27272859 1.00 HDAC4 (0.42) HDAC4NPC1CASP3RAB9ASMN1; SMN2
SCHEMBL27272888 0.82 SLC22A12 (0.47) HDAC4CD38GSK3BDYRK1ACLK2
SCHEMBL30987723 0.82 SLC22A12 (0.47) HDAC4CD38GSK3BDYRK1ACLK2
SCHEMBL1785648 0.81 MEN1 (0.44) SMN1; SMN2CD38IMPDH2IMPDH1ABL1
SCHEMBL3348427 0.79 NR4A2 (0.58) HDAC4NPC1RAB9ASLC6A4SLC6A3
SCHEMBL27272844 0.78 CTSK (0.43) NPC1CASP3RAB9ASMN1; SMN2SENP8
SCHEMBL30987780 0.78 CTSK (0.43) NPC1CASP3RAB9ASMN1; SMN2SENP8
SCHEMBL1307654 0.78 TUBB4A (0.51) —
SCHEMBL21826334 0.76 CA12 (0.50) NPC1RAB9AALDH1A1
Hydrochloric Acid SCHEMBL6244513 0.75 GABRG2 (0.49) NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676929-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 Dark Blue Therapeutics Ltd (GB) 2026-01-14 — — EP disclosed
EP-4638447-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS Dark Blue Therapeutics Ltd (GB) 2025-10-29 — — EP disclosed
WO-2024188906-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 DARK BLUE THERAPEUTICS LTD (GB) 2024-09-19 — — WO disclosed
WO-2024133560-A1 IMIDAZO[1,2-A]PYRIDINE AND IMIDAZO[1,2-A]PYRAZINE DERIVATIVES AS MLLT1 AND MLLT3 INHIBITORS DARK BLUE THERAPEUTICS LTD (GB) 2024-06-27 — — WO disclosed
Send feedback